|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.10 USD | -0.82% |
|
-2.29% | +4.37% |
| Jun. 08 | Gilead, Merck HIV Combination Meets Primary Endpoint in Two Phase 3 Trials | MT |
| Jun. 08 | Merck, Gilead End Lung Cancer Trial, Report Positive Data From HIV Drug Trials | DJ |
Official Publications
| May. 19 | SEC Filing 8K | CO |
| May. 06 | SEC Filing 8K | CO |
| May. 06 | SEC Filing 10Q-1 | CO |
| May. 06 | Slide show Q1 | CO |
| May. 06 | 1st quarter results | CO |
| Feb. 23 | SEC Filing 10K | CO |
| Feb. 09 | SEC Filing 8K | CO |
| Feb. 09 | Slide show results | CO |
| Feb. 09 | Annual results | CO |
| Feb. 04 | SEC Filing 13G | CO |
| Nov. 06 | SEC Filing 10Q-3 | CO |
| 25-10-29 | SEC Filing 8K | CO |
| 25-10-29 | Slide show Q3 | CO |
| 25-10-29 | 3rd quarter results | CO |
| 25-08-06 | SEC Filing 8K | CO |
| 25-08-06 | SEC Filing 10Q-2 | CO |
| 25-08-06 | Slide show half-year results | CO |
| 25-08-06 | 1st-half-year results | CO |
| 25-05-06 | Shareholders meeting voting results | CO |
| 25-05-06 | SEC Filing 10Q-1 | CO |
| 25-04-23 | SEC Filing 8K | CO |
| 25-04-23 | Slide show Q1 | CO |
| 25-04-23 | 1st quarter results | CO |
| 25-03-26 | Proxy Statments | CO |
| 25-02-27 | SEC Filing 10K | CO |
- Stock Market
- Stocks
- GILD Stock
- News Gilead Sciences, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions

















